References
- Denomme G. Titers of ABO antibodies in group O blood donors: patient safety and blood product supply remain a challenge. Rev Bras Hematol Hemater 2011;33;250–8.
- Karafin MS, Blagg L, Tobian AAR, King KE, Ness PM, Savage Wj. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012;52:2087–93.
- Blumberg N, Refaai M, Heal J. ABO matching of platelet transfusions: “Start Making Sense.” Blood Transfus 2015;13:347–50.
- Harm SK, Yazer MH, Bub CB, et al. Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelets, and whole blood units tested by different methods. Transfusion 2019;59:762–67.
- Standards for blood banks and transfusion services. 31st ed. Arlington, VA: AABB, 2018:37–8.
- Cid J, Harm SK, Yazer MH. Platelet transfusion: the art and science of compromise. Transfus Med Hemother 2013;40; 160–71.
- Dunbar NM, Katus MC, Freeman CM, Szczepiorkowski ZM. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions. Transfusion 2015;55:1882–8.
- Fontaine MJ, Webster J, Gomez S, Pham TD, Goodnough LT, Galel SA. How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets? Transfusion 2015;55:2783–9.
- Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma a survey of 3156 North American Laboratories. Arch Pathol Lab Med 2007;131: 909–16.
- Dunbar NM, Ornstein DL, Dumont LJ. ABO incompatible platelets: risk versus benefit. Curr Opin Hematol 2012;19: 475–9.
- Chaudhary R, Sekhar Das S, Khetan D, Ojha S, Verma S. Comparative study of automated platelet apheresis using five different apheresis systems in a tertiary care hospital. Transfus Apher Sci 2009;40:99–103.
- Berséus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion 2013;53:114S–123S.
- Strandenes G, Berseus O, Cap AP, et al. Low titer group O whole blood in emergency situations. Shock 2014;41:70–75.
- Flegel WA. Pathogenesis and mechanism of antibody-mediated hemolysis. Transfusion 2015;55:S47–S58.
- Hinz A, Enkel S, Zimmermann B, Lang P, Bakchoul T. Post transfusion hemolysis in a stem cell transplanted pediatric patient after receiving an apheresis platelet unit with high-titer Anti-A (abstract). Transfusionsmedizin 2018;8:160–3.
- Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000;40:902–6.
- Sadani DT, Urbaniak SJ, Bruce M, Tighe JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med 2006;16:375–9.
- Shachner TR, Clark CT. Acute hemolytic transfusion reaction in group B recipient associated with group A apheresis platelet donor: case report and literature review. Case Rep Med 2018, article ID 8259531.
- Reis MD, Coovadia AS. Transfusion of ABO-incompatible platelets causing severe haemolytic reaction. Clin Lab Haemat 1989;11:237–40.
- Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 1985;25:60–62.
- Cunnion KM, Hair PS, Krishna NK, et al. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay. Transfusion 2016;56:1845–8.
- Valbonesi M, De Luigi MC, Lercari G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs 2000;23:642–6.
- Balbuena-Merle R, West BF, Tormey CA, Hendrickson JE. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution. Transfusion 2019;59:1911–5.
- Fontaine MJ, Mills AM, Weiss S, Hong WJ, Viele M, Goodnough LT. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products. Transfusion 2012;52:2081–5.
- Blumberg N, Heal JM, Hicks GL, Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion 2001;41:790–3.
- FDA archived fatalities data due to transfusion/donation. Available from https://www.fda.gov/vaccines-blood-biologics/report-problem-center-biologics-evaluation-research/transfusiondonation-fatalities. Accessed 18 March 2019.
- Karafin M, Fuller AK, Savage WJ, King KE, Ness PM, Tobian AAR. The impact of apheresis platelet manipulation on corrected count increment. Transfusion 2012;52:1221–7.
- Fung MK, Eder AF, Spitalnik SL, Westhoff CM. Technical manual. 19th ed. Bethesda, MD: AABB, 2017.
- Josephson CD, Castillejo MI, Grima K, Hillyer CD. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci 2010;42:83–8.
- Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A,B: implications for transfusion policy. Transfusion 2004;44:805–8.
- Weisberg SP, Shax BH, Tumer G, Silliman CC, Kelher MR, Cohn CS. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets. Transfusion 2018;58:891–5.
- Gulliksson H. Platelet storage media. Vox Sang 2014;107: 205–12.
- Crosby WH, Akeroyd JH. Some immunohematologic results of large transfusions of group O blood in recipients of other blood groups. Blood 1954;9;103–16.
- Barns A. Transfusion of universal donor and uncrossmatched blood. Bibl Haematol 1980;46:132–42.
- Pietersz R, Engelfriet C, Reesink H. Transfusion of apheresis platelets and ABO groups. Vox Sang 2005;88:207–21.
- Cooling LL, Downs TA, Butch SH, Davenport RD. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets. Transfusion 2008;48:2106–13.
- AuBuchon JP, Wildt-Eggen de J, Dumont LJ. Reducing the variation in performance of antibody titrations. Arch Pathol Lab Med 2008;132:1194–201.
- Bachegowda LS, Cheng YH, Long T, Shaz BH. Impact of uniform methods on interlaboratory antibody titration variability. Arch Pathol Lab Med 2017;141:131–8.
- Seheult JN, Anto V, Alarcon LH, Sperry JL, Triulzi DJ, Yazer MH. Clinical outcomes among low-titer group O whole blood recipients compared to recipients of conventional components in civilian trauma resuscitation. Transfusion 2018;58: 1838–45.
- Vanderspurt CK, Spinella PC, Cap AP et al. The use of whole blood in US military operations in Iraq, Syria, and Afghanistan since the introduction of low-titer type O whole blood: feasibility, acceptability, challenges. Transfusion 2019;59:965–70.
- Condron M, Scanlan M, Schreiber M. Massive transfusion of low-titer cold-stored O-positive whole blood in civilian trauma setting. Transfusion 2019;59:927–30.
- Park ES, Jo KI, Shin JW, et al. Comparison of total and IgG ABO antibody titers in healthy individuals by using tube and column agglutination techniques. Ann Lab Med 2014;34: 223–9.
- Kang SJ, Lim YA, Baik SY. Comparison of ABO antibody titers on the basis of the antibody detection method used. Ann Lab Med 2014;34:300.
- Matsuura H, Akatsuka Y, Matsuno T, et al. Comparison of the tube test and column agglutination techniques for anti-A/-B antibody titration in healthy individuals. Vox Sang 2018;113:787–94.
- Quillen K, Sheldon SL, Daniel-Johnson JL, Lee-Stroka H, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies. Transfusion 2011;51:92–6.
- ARUP Laboratory Test Directory. Available from http://ltd.aruplab.com/tests/pub/2000280. Accessed 23 May 2017.
- Boorman KE, Dodd BE, Mollison PL. Iso-immunisation to the blood-group factors A, B and Rh. J Pathol Bacteriol 1945;57:157–69.
- Koskela P, Nurmi T, Haiva V-M. IgA, IgG and IgM anti-blood group A antibodies induced by pneumococcal vaccine. Vaccine 1988;6:221–2.
- Bourke GJ, Clarke N. Smallpox vaccination and serum anti-A levels. Acta Genet Stat Med 1965;15:13–20.
- Gupte SC, Bhatia HM. Anti-A and anti-B titer response after tetanus toxoid injections in normal adults and pregnant women. Indian J Med Res 1979;70:221–8.
- Daniel-Johnson J, Leitman S, Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion 2009;49:1845–9.
- McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products. Am J Clin Pathol 1999;111:202–6.
- Galvão de França ND, Cristovão Poli MC, Almeida Ramos PG, Rocha Borsoi CS, Colella R. Titers of ABO antibodies in group O blood donors. Rev Bras Hematol Hemoter 2011;33:259–262.
- Bazigou F, Lempesopoulos K, Kavallierou L, et al. Evaluation of anti-A and anti-B alloisogglutinin titer in group O plateletpheresis donors. Hematol Transfus Int J 2015;1:00017.
- Byrne KM, Sheldon SL, Flegel WA. Organization and management of an accredited Specialist in Blood Bank (SBB) Technology program. Transfusion 2010;50:1612–7.